公开(公告)号：US07405210B2

公开(公告)日：2008-07-29

申请号：US10851902

申请日：2004-05-20

Applicant: Stuart Edward Bradley ,  Thomas Martin Krulle ,  Peter John Murray ,  Martin James Procter ,  Robert John Rowley ,  Colin Peter Sambrook Smith ,  Gerard Hugh Thomas

Inventor： Stuart Edward Bradley ,  Thomas Martin Krulle ,  Peter John Murray ,  Martin James Procter ,  Robert John Rowley ,  Colin Peter Sambrook Smith ,  Gerard Hugh Thomas

IPC: C07D471/02 ,  A61K31/44

CPC classification number: C07D471/04

Abstract: Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, and as cardioprotectants.

Abstract translation: 由式（I）表示的化合物或其药学上可接受的盐是糖原磷酸化酶的抑制剂，可用于预防或治疗糖尿病，高血糖症，高胆固醇血症，高胰岛素血症，高脂血症，高血压，动脉粥样硬化或组织缺血。 心肌缺血，以及心脏保护剂。

公开(公告)号：US08274913B2

公开(公告)日：2012-09-25

申请号：US12188529

申请日：2008-08-08

Applicant: Stuart Edward Ralston

Inventor： Stuart Edward Ralston

IPC: H04L12/28

CPC classification number: H04W4/02 ,  H04L67/18 ,  H04L69/24 ,  H04W8/005

Abstract: A method and system for configuring wireless communication of survey sensors and controllers is recited. In one embodiment, a survey device controller is configured to receive a first wireless communication comprising a sequence indicating that a survey device is configured to participate in an automatic configuration process with the survey device controller. The system further comprises the survey device which is configured to generate a second wireless communication indicating the reception of a selection event to communicatively couple the survey device with the survey device controller. The survey device controller is further configured to automatically initiate a wireless communication connection comprising the survey device controller and the survey device in response to receiving the second wireless signal contemporaneous with receiving a signal which is generated by the survey device controller to communicatively couple the survey device controller with the survey device.

Abstract translation: 列举了用于配置测量传感器和控制器的无线通信的方法和系统。 在一个实施例中，测量设备控制器被配置为接收第一无线通信，其包括指示测量设备被配置为参与与测量设备控制器的自动配置过程的序列。 该系统还包括测量设​​备，其被配置为生成指示接收选择事件的第二无线通信，以将测量设备与测量设备控制器通信地耦合。 所述测量装置控制器还被配置为响应于接收到由所述测量设备控制器产生的信号同时接收到所述第二无线信号而自动启动包括所述测量设备控制器和所述测量设备的无线通信连接，以将所述测量设备 控制器与测量设备。

公开(公告)号：US08173807B2

公开(公告)日：2012-05-08

申请号：US11794641

申请日：2005-12-30

Applicant: Stuart Edward Bradley ,  Matthew Colin Thor Fyfe ,  Gerard Hugh Thomas

Inventor： Stuart Edward Bradley ,  Matthew Colin Thor Fyfe ,  Gerard Hugh Thomas

IPC: A61K31/506 ,  A61K31/4545 ,  C07D401/14 ,  A61P3/00 ,  A61P3/04 ,  A61P3/10

CPC classification number: C07D401/14

Abstract: Compounds of formula (I): R1-A-V—B—R2, wherein V is phenyl or a 6-membered heteroaryl ring containing up to three N-atoms, or pharmaceutically acceptable salts thereof, are agonists of GPR116 and are useful for the treatment of obesity, and for the treatment of diabetes.

Abstract translation: 式（I）化合物：其中V是苯基或含有至多3个N原子的6元杂芳基的R1-AV-B-R2或其药学上可接受的盐是GPR116的激动剂，可用于治疗 的肥胖症和治疗糖尿病。

公开(公告)号：US20110086885A1

公开(公告)日：2011-04-14

申请号：US11794939

申请日：2005-11-25

Applicant: Stuart Edward Bradley ,  Thomas Martin Krulle ,  Gerard Hugh Thomas

Inventor： Stuart Edward Bradley ,  Thomas Martin Krulle ,  Gerard Hugh Thomas

IPC: A61K31/4439 ,  C07D209/04 ,  A61K31/404 ,  C07D405/12 ,  C07D401/12 ,  A61P3/10 ,  A61P9/12 ,  A61P9/10

CPC classification number: C07D405/12 ,  C07D209/42 ,  C07D401/12

Abstract: Compounds represented by Formula (I) or pharmaceutically acceptable salts thereof, are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, and as cardioprotectants.

Abstract translation: 由式（I）表示的化合物或其药学上可接受的盐可用于糖尿病，高血糖症，高胆固醇血症，高胰岛素血症，高脂血症，高血压，动脉粥样硬化或组织缺血的预防或治疗性治疗。 心肌缺血，以及心脏保护剂。

公开(公告)号：US20090266295A1

公开(公告)日：2009-10-29

申请号：US11913561

申请日：2006-05-08

Applicant: Stuart Edward Saunders

Inventor： Stuart Edward Saunders

IPC: B05B9/04

CPC classification number: B05C17/002 ,  B05B1/20 ,  B05B9/007 ,  B05B9/0838 ,  B05B15/652 ,  B05C17/00516 ,  E04F21/08

Abstract: Apparatus (10) for applying adhesive to a surface to be tiled has a container (11) for the adhesive and a pair of opposed end walls (12,14) at least one of which is removable. The container has an outlet port (24) and one end wall (14) supports a plunger (19,23) for driving adhesive through the port (24) out of the container A drive mechanism such as a hydraulic ram (17) is provided on that one end wall (14) to cause movement of the plunger (19,23). A multi-outlet nozzle (26) for adhesive is connected by a duct (25) to the outlet port so that a plurality of beads of the adhesive are laid on the surface to be tiled.

Abstract translation: 用于将粘合剂施加到待铺平的表面上的装置（10）具有用于粘合剂的容器（11）和一对相对的端壁（12,14），其中至少一个可移除。 容器具有出口（24），一个端壁（14）支撑用于将粘合剂通过端口（24）驱动出容器的柱塞（19,23）。提供了诸如液压柱塞（17）的驱动机构 在该一个端壁（14）上以引起柱塞（19,23）的移动。 用于粘合剂的多出口喷嘴（26）通过管道（25）连接到出口，使得粘合剂的多个珠粒铺设在待铺平的表面上。

公开(公告)号：US06504037B2

公开(公告)日：2003-01-07

申请号：US09801999

申请日：2001-03-08

Applicant: Stuart Edward Bradley ,  John Kitchin ,  Graham Michael Wynne

Inventor： Stuart Edward Bradley ,  John Kitchin ,  Graham Michael Wynne

IPC: C07D31100

CPC classification number: C07D317/72 ,  C07C37/07 ,  C07C45/59 ,  C07C45/71 ,  C07C49/747 ,  C07C2601/14 ,  C07C2601/18 ,  Y02P20/55 ,  Y10S977/926 ,  C07C49/753 ,  C07C39/17

Abstract: The present invention relates to an improved process for preparing 4-substituted resorcinol derivatives, and intermediate compounds useful in the preparation of such resorcinol derivatives.

公开(公告)号：US20130283337A1

公开(公告)日：2013-10-24

申请号：US13453966

申请日：2012-04-23

Applicant: Stuart Edward Schechter ,  Cormac Herley

Inventor： Stuart Edward Schechter ,  Cormac Herley

IPC: G06F21/00

CPC classification number: G06F21/46

Abstract: A current prefix character string representing a prefix of a proposed password may be obtained from a user input device. A prediction of a most likely next character of the proposed password may be determined, based on applying a set of heuristics to the current prefix character string. A response indicating an impact on a security strength of the proposed password may be determined, based on a selection of the predicted most likely next character.

Abstract translation: 可以从用户输入设备获得表示建议密码的前缀的当前前缀字符串。 可以基于将一组启发式应用于当前前缀字符串来确定提出的密码的最可能的下一个字符的预测。 可以基于预测的最可能的下一个字符的选择来确定指示对所提出的密码的安全强度的影响的响应。

公开(公告)号：US08473519B1

公开(公告)日：2013-06-25

申请号：US12036906

申请日：2008-02-25

Applicant: Talal Ahmad Siddiqui ,  Ramesh Kumar Kaza ,  Stuart Edward Biggs ,  Sanjay Jani ,  Narayanan Thyagarajan

Inventor： Talal Ahmad Siddiqui ,  Ramesh Kumar Kaza ,  Stuart Edward Biggs ,  Sanjay Jani ,  Narayanan Thyagarajan

IPC: G06F17/30

CPC classification number: G06F17/30864 ,  G06F11/3409 ,  G06F17/30 ,  G06F17/303 ,  G06F17/30424 ,  H04L29/00 ,  H04L41/0213 ,  H04L41/0853 ,  H04L41/0856 ,  H04L67/02

Abstract: Providing for dynamic auditing of components of a communication network is provided herein. By way of example, network components can be queried by way of dynamic and intelligent application programming interface (APIs) queries to extract data for the network components. Such data can then be compared with best practice rules to identify potential enhancements to efficiency or scalability of such components. In some aspects, an audit report can be output summarizing identified enhancements. In other aspects, data can be written to an updated component according to protocols suited to such component. Accordingly, an audit can provide feedback in light of best practices or can be utilized to dynamically upgrade a legacy system to newer system software and/or hardware components.

公开(公告)号：US20120172358A1

公开(公告)日：2012-07-05

申请号：US13396193

申请日：2012-02-14

Applicant: Stuart Edward Bradley ,  Matthew Colin Thor Fyfe ,  Lisa Sarah Bertram ,  William Gattrell ,  Revathy Perpetua Jeevaratnam ,  John Keily ,  Martin James Procter ,  Chrystelle Marie Rasamison ,  Philip John Rushworth ,  Colin Peter Sambrook-Smith ,  David French Stonehouse ,  Simon Andrew Swain ,  Geoffrey Martyn Williams

Inventor： Stuart Edward Bradley ,  Matthew Colin Thor Fyfe ,  Lisa Sarah Bertram ,  William Gattrell ,  Revathy Perpetua Jeevaratnam ,  John Keily ,  Martin James Procter ,  Chrystelle Marie Rasamison ,  Philip John Rushworth ,  Colin Peter Sambrook-Smith ,  David French Stonehouse ,  Simon Andrew Swain ,  Geoffrey Martyn Williams

IPC: A61K31/445 ,  C07D401/10 ,  C07D413/12 ,  C07D401/04 ,  A61K31/454 ,  A61P3/06 ,  A61K31/496 ,  A61K31/5377 ,  A61K31/506 ,  A61P3/00 ,  A61P3/04 ,  A61P3/10 ,  C07D211/34 ,  A61K31/4545

CPC classification number: C07D401/14 ,  C07D211/20 ,  C07D211/22 ,  C07D211/24 ,  C07D211/26 ,  C07D211/28 ,  C07D211/34 ,  C07D211/48 ,  C07D401/04 ,  C07D401/10 ,  C07D401/12

Abstract: Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.

Abstract translation: 式（I）化合物或其药学上可接受的盐是GPCR激动剂，可用于治疗肥胖症和糖尿病。

公开(公告)号：US08158622B2

公开(公告)日：2012-04-17

申请号：US12217157

申请日：2008-07-02

Applicant: Stuart Edward Bradley ,  Thomas Martin Krulle ,  Peter John Murray ,  Martin James Procter ,  Robert John Rowley ,  Colin Peter Sambrook Smith ,  Gerard Hugh Thomas ,  Karen Lesley Schofield

Inventor： Stuart Edward Bradley ,  Thomas Martin Krulle ,  Peter John Murray ,  Martin James Procter ,  Robert John Rowley ,  Colin Peter Sambrook Smith ,  Gerard Hugh Thomas ,  Karen Lesley Schofield

IPC: C07D471/02 ,  A61K31/44

CPC classification number: C07D471/04

Abstract: Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, and as cardioprotectants.

Abstract translation: 由式（I）表示的化合物或其药学上可接受的盐是糖原磷酸化酶的抑制剂，可用于预防或治疗糖尿病，高血糖症，高胆固醇血症，高胰岛素血症，高脂血症，高血压，动脉粥样硬化或组织缺血。 心肌缺血，以及心脏保护剂。